Companies

CGenetix

Pépinière Genopole, 4 rue Pierre Fontaine
91000 Evry-Courcouronnes

Geoffroy POULET: CEO
Contact: geoffroy.poulet@cgenetix.com

Site Web >

Shaker #health and well-being #diagnostics #medical devices

Kidney transplant
Circulating DNA
Digital PCR
Precision analysis

Field of activity

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

BACKGROUND

Laureate of the Shaker programme in 2021 and of the Gene.io programme; in 2022
Réseau Entreprendre laureate in March 2022
Deep tech laureate, French Tech Emergence grant in April 2022
First patent filed in August 2022

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

Class C in vitro diagnostic tests to quantify organ lesions via a blood sample. CGenetix’s test is based on the analysis of molecular signatures present in the circulating DNA released by transplanted kidneys during immune rejection.

ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS

Clinical partnership with the renal transplant departments of the Necker and Tenon Hospitals (AP-HP) in July 2022.
Clinical partnership with the nephrology departments of the Bicêtres Hospital and South Île-de-France Medical Center.

COLLABORATIONS SOUGHT

Partnerships with pharmaceutical companies developing graft-rejection-limiting treatments.
Partnerships with solid-organ-transplantation reference hospitals (kidney and/or other).

Further information

1 patent

Strengths:
Dynamic, multidisciplinary team, a clear company vision, quickly growing market

Innovation assets:
Rapid, affordable, ultra-sensitive, ultra-specific, non-invasive technology.

Genopole’s Companies

#Diagnostics

In the same field

EndoGene.Bio

Research & development for an in vitro diagnostic tool for endometriosis

Discover

SafeInsight

SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.

Discover

Floating Genes

Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.

Discover

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover

View all >

With the support from